Driving Quality, Compliance, and Continuity Across the Medical Device Lifecycle
Ensure total regulatory compliance, patient safety, and accelerated market access with QCLYNX’s customized, cost-effective quality and validation solutions. Built for modern MedTech manufacturers and Software as a Medical Device (SaMD) innovators, our services protect business continuity, mitigate design and production risk, and elevate product quality from early-stage conceptualization through commercial release.
Quality & Compliance Excellence for the Next-Gen Medical Device Industry
The MedTech ecosystem is evolving rapidly—expanding from traditional hardware equipment to smart connected wearables, Software as a Medical Device (SaMD), AI/ML-driven diagnostics, and complex combination products. Despite these rapid technological leaps, global regulatory expectations remain rigorous and uncompromising. Regulatory authorities enforce strict oversight, where design flaws, inadequate risk management, or compliance oversights lead to warning letters, delayed 510(k)/PMA approvals, costly product recalls, and severe operational disruptions. Medical device executives must continuously balance aggressive launch timelines with full regulatory adherence. QCLYNX acts as a trusted global compliance partner. We turn regulatory requirements into strategic advantages by engineering ISO 14971-aligned risk management frameworks, modernizing device software validation, and ensuring seamless compliance across the entire product lifecycle.
Our Core Offerings
Trusted Services for Medical Device Industry
Medical Device Software Validation (SaMD & Embedded Software)
Risk-based validation for Software as a Medical Device (SaMD), firmware, mobile medical apps, and SiMD (Software in a Medical Device) compliant with IEC 62304 and FDA guidance.
Quality Management System Setup (ISO 13485 & FDA QMSR)
Design, configuration, and audit-ready deployment of Quality Management Systems harmonized with ISO 13485:2016 and the FDA Quality Management System Regulation (QMSR / 21 CFR Part 820).
Design Controls & DHF Remediation
End-to-end management of Design History Files (DHF), verification and validation (V&V) protocols, design inputs/outputs, and traceability matrices.
Risk Management & ISO 14971 Integration
Application of structured risk management protocols across the device lifecycle, including dFMEA, pFMEA, usability risk analysis (IEC 62366), and post-market risk surveillance.
Equipment & Manufacturing Process Validation (IQ/OQ/PQ)
Qualification of automated assembly lines, sterilizers, cleanrooms, packaging lines, and production tools under strict process validation guidelines.
We are here to help you.
End-to-End Product Lifecycle Partnership
Building on proven life science leadership, QCLYNX empowers MedTech innovators by harnessing modern technological breakthroughs and agile compliance frameworks. Driven by a commitment to continuous innovation, we regularly expand our service capabilities to ensure our medical device and digital health partners achieve sustainable success and global regulatory approvals.
We conduct gap assessments and update legacy QMS frameworks (21 CFR Part 820) to seamlessly harmonize with ISO 13485:2016 expectations while preserving critical FDA post-market reporting requirements (MDR, Part 803).
Yes. We execute complete software lifecycle validation under IEC 62304, FDA SaMD guidance, and GAMP® 5, ensuring your software architecture, cybersecurity controls, and algorithm verification meet global authority expectations.
We construct, organize, and remediate DHFs by mapping user needs to technical specifications, verifying test protocols (V&V), executing usability testing (IEC 62366), and maintaining strict risk-to-design traceability.
We validate the full range of GxP digital systems, including Enterprise Resource Planning (ERP), Manufacturing Execution Systems (MES), electronic Device History Record (eDHR) platforms, LIMS, and eQMS tools.